Literature DB >> 950372

Free and protein-bound plasma estradiol-17 beta during the menstrual cycle.

C H Wu, T Motohashi, H A Abdel-Rahman, G L Flickinger, G Mikhail.   

Abstract

Methods are described for the measurement of the estradiol-binding capacity of TeBG and of the free, TeBG-bound, and non-specifically protein-bound fractions of plasma estradiol. Each determination used undiluted plasma at 37 C, and a total volume of less than 2.0 ml of plasma was required to complete all the assays. The measurement of the per cent of free estradiol was affected by changes in plasma dilution. The measurement of the other fractions of estradiol was not influenced by changes in either the dilution or the volume of plasma. The distribution of plasma estradiol was determined daily throughout 5 individual menstrual cycles. The per cent of free, the per cent of TeBG-bound, and the TeBG binding capacity of estradiol remained constant throughout the cycle with mean values of 2.21 +/- 0.04% (SE), 38.4 +/- 0.7%, and 16.6 +/- 0.43 ng/ml, respectively. The mean association constant of TeBG for estradiol was 6.58 +/- 0.25 x 10(7)M-1. The concentration of the free and non-specifically protein-bound fractions of estradiol paralleled the total plasma concentration of estradiol. The results show that biologic events related to normal cyclic changes of plasma estradiol may be attributed to fluctuations in the free estradiol and to estradiol which is bound with low affinity to non-specific plasma proteins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 950372     DOI: 10.1210/jcem-43-2-436

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  12 in total

Review 1.  Estrogens.

Authors:  Gary E Ackerman; Bruce R Carr
Journal:  Rev Endocr Metab Disord       Date:  2002-09       Impact factor: 6.514

2.  Global Dynamics of a Breast Cancer Competition Model.

Authors:  Kristen Abernathy; Zachary Abernathy; Arden Baxter; Meghan Stevens
Journal:  Differ Equ Dyn Syst       Date:  2017-01-20

3.  CB1 agonism prolongs therapeutic window for hormone replacement in ovariectomized mice.

Authors:  Kun Zhang; Qi Yang; Le Yang; Yan-Jiao Li; Xin-Shang Wang; Yu-Jiao Li; Rui-Li Dang; Shao-Yu Guan; Yan-Yan Guo; Ting Sun; Yu-Mei Wu; An Liu; Yan Zhang; Shui-Bing Liu; Ming-Gao Zhao
Journal:  J Clin Invest       Date:  2019-05-06       Impact factor: 14.808

4.  Mechanisms of resistance to structurally diverse antiestrogens differ under premenopausal and postmenopausal conditions: evidence from in vitro breast cancer cell models.

Authors:  Ping Fan; Wei Yue; Ji-Ping Wang; Sarah Aiyar; Yan Li; Tae-Hyun Kim; Richard J Santen
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

5.  Sex hormone binding globulin as a reliable indicator of hormone dependence in human breast cancer.

Authors:  Y Murayama; J Utsunomiya; I Takahashi; M Kitamura; T Tominaga
Journal:  Ann Surg       Date:  1979-08       Impact factor: 12.969

6.  Testosterone-estradiol-binding globulin, unbound and total estradiol and testosterone, and total progesterone during the menstrual cycle in women with epilepsy taking antiepileptic drugs.

Authors:  C T Bäckström; R Södergård
Journal:  J Endocrinol Invest       Date:  1979 Oct-Dec       Impact factor: 4.256

7.  Genesis of breast cancer in Japanese: a possible relationship between sex hormone binding globulin (SHBG) and serum lipid components.

Authors:  O Takatani; T Okumoto; H Kosano
Journal:  Breast Cancer Res Treat       Date:  1991-05       Impact factor: 4.872

8.  Effects of prednisolone on sex hormone binding globulin during primary endocrine treatment of advanced breast cancer.

Authors:  D Y Wang; R D Rubens; G M Clark; J W Moore; R D Bulbrook
Journal:  Breast Cancer Res Treat       Date:  1988-04       Impact factor: 4.872

9.  Estradiol induces allosteric coupling and partitioning of sex-hormone-binding globulin monomers among conformational states.

Authors:  Ravi Jasuja; Daniel Spencer; Abhilash Jayaraj; Liming Peng; Meenakshi Krishna; Brian Lawney; Priyank Patel; Bhyravabhotla Jayaram; Kelly M Thayer; David L Beveridge; Shalender Bhasin
Journal:  iScience       Date:  2021-04-09

10.  Estradiol Binds to Insulin and Insulin Receptor Decreasing Insulin Binding in vitro.

Authors:  Robert Root-Bernstein; Abigail Podufaly; Patrick F Dillon
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-21       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.